Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine in Relapsed or Refractory Diffuse Large Cell B-Cell NHL
NCT00156013Phase 2Completed
- Sponsor
- Oncology Specialists
- Start
- Sep 2005
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in diffuse large B-cell lymphoma (DLBCL), sponsored by Oncology Specialists. Started Sep 2005; status: completed.
02
Drugs
clofarabine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00156013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156013.